GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Medical & HealthCare Group Ltd (HKSE:00383) » Definitions » ROCE %
中文

China Medical & HealthCare Group (HKSE:00383) ROCE % : 4.53% (As of Dec. 2023)


View and export this data going back to 1991. Start your Free Trial

What is China Medical & HealthCare Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. China Medical & HealthCare Group's annualized ROCE % for the quarter that ended in Dec. 2023 was 4.53%.


China Medical & HealthCare Group ROCE % Historical Data

The historical data trend for China Medical & HealthCare Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Medical & HealthCare Group ROCE % Chart

China Medical & HealthCare Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.64 -2.13 -2.35 -2.73 3.64

China Medical & HealthCare Group Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.04 -0.71 -4.89 2.67 4.53

China Medical & HealthCare Group ROCE % Calculation

China Medical & HealthCare Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=83.211/( ( (3232.534 - 1130.718) + (3617.395 - 1144.872) )/ 2 )
=83.211/( (2101.816+2472.523)/ 2 )
=83.211/2287.1695
=3.64 %

China Medical & HealthCare Group's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=107.778/( ( (3439.059 - 1155.261) + (3617.395 - 1144.872) )/ 2 )
=107.778/( ( 2283.798 + 2472.523 )/ 2 )
=107.778/2378.1605
=4.53 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Medical & HealthCare Group  (HKSE:00383) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


China Medical & HealthCare Group ROCE % Related Terms

Thank you for viewing the detailed overview of China Medical & HealthCare Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


China Medical & HealthCare Group (HKSE:00383) Business Description

Traded in Other Exchanges
Address
333 Lockhart Road, 47th Floor, United Asia Finance Centre, Wanchai, Hong Kong, HKG
China Medical & HealthCare Group Ltd is a healthcare company operating hospitals. Its main focus is on the investment, management, and operations of healthcare and hospital businesses, eldercare businesses, trading of medical equipment and related supplies, property investment and development, securities trading and investments, provision of financial services, and strategic investment. It operates through the following business segments: Healthcare, Eldercare; Property development; Property investment; Financial services; and Securities trading and investments. The firm generates the majority of revenue from the Healthcare segment that is engaged in the operations of hospitals in the PRC.

China Medical & HealthCare Group (HKSE:00383) Headlines

No Headlines